Wednesday, November 19, 2014
Print Current Day:
|
|
SESSION 25 SCHEDULE | |
Wednesday
SESSION 25:
EXCITING NEW TECHNOLOGY AND TECHNIQUES
Moderators:Ronald L. Dalman, MD / Kenneth Ouriel, MD, MBA
|
|
x | |
6:45 AM - 6:50 AM | 4 French Instrumentation For Lower Extremity Disease Treatment As An Outpatient: Experience In >2000 Patients Over 10 Years: How To Do It |
Presenter(s):Jos C. van den Berg, MD, PhD | |
View Abstract | |
6:51 AM - 6:56 AM | Role Of Endovascular Adventitial Drug Delivery To Prevent Restenosis: The Bullfrog Catheter System |
Presenter(s):Christopher D. Owens, MD | |
View Abstract | |
6:57 AM - 7:02 AM | A New Endovascular Balloon And A New Temporary Vascular Shunt To Help Treat Vascular Injury, Hemorrhage And Shock |
Presenter(s):Todd E. Rasmussen, MD, FACS | |
View Abstract | |
7:03 AM - 7:08 AM | TAVR For Pure Aortic Insufficiency: How To Make It Work And What Is Left For Surgical Valve Repair |
Presenter(s):Dietmar H. Koschyk, MD | |
View Abstract | |
7:09 AM - 7:14 AM | Percussion Crossing Device For Calcified CTOs: How Does It Work And Early Results Of Piculet Hammer Device |
Presenter(s):Max Amor, MD | |
7:15 AM - 7:20 AM | Will Drug-Eluting Fully Bioabsorbable Scaffolds Prove Advantageous In The Coronary Arteries |
Presenter(s):Gregg W. Stone, MD | |
View Abstract | |
7:21 AM - 7:26 AM | Some Innovative New Devices From Tim Chuter: The Inch Worm Balloon; The Shapeshifter Catheter And Microstents |
Presenter(s):Timothy A.M. Chuter, DM | |
View Abstract | |
7:27 AM - 7:32 AM | Panel Discussion |
END OF SESSION 25 | |
SESSION 26 SCHEDULE | |
Wednesday
SESSION 26:
NEW INFORMATION ABOUT PARALLEL GRAFTS CHIMNEYS, PERISCOPES AND SANDWICH GRAFTS (CHIMPS) FOR TAAAs
Moderators:Timur P. Sarac, MD / Giovanni Torsello, MD
|
|
x | |
7:32 AM - 7:37 AM | Current Role Of Chimneys And Parallel Grafts For The Treatment Of Complex Aortic Aneurysms |
Presenter(s):Frank J. Criado, MD, FACS, FSVM | |
View Abstract | |
7:38 AM - 7:43 AM | Value And Limitations Of Periscope Grafts For Distal TAAAs |
Presenter(s):Jason T. Lee, MD | |
View Abstract | |
7:44 AM - 7:49 AM | Brazilian Registry Of Sandwich Technique Repairs For TAAAs: Mid-Term Results And How Do They Compare With Results Of Fenestrated And Branched Repairs |
Presenter(s):Armando C. Lobato, MD, PhD | |
View Abstract | |
7:50 AM - 7:55 AM | The Eye Of The Tiger Technique To Eliminate Gutter Endoleaks With Parallel Grafts |
Presenter(s):David J. Minion, MD | |
View Abstract | |
7:56 AM - 8:01 AM | Late Outcomes Of Thoracic And Visceral Chimney Grafts: Are They Durable |
Presenter(s):Martin Malina, MD, PhD | |
View Abstract | |
8:02 AM - 8:07 AM | DEBATE: Mid-Term Results Of Sandwich Grafts For TAAAs Equal Those Of Branched Endografts |
Presenter(s):Ralf R. Kolvenbach, MD | |
View Abstract | |
8:08 AM - 8:13 AM | DEBATE: Branched Endografts Are Better Treatment For TAAAs Than Sandwich Grafts Or Other Parallel Grafts |
Presenter(s):Stephan Haulon, MD | |
View Abstract | |
8:14 AM - 8:20 AM | Panel Discussion |
END OF SESSION 26 | |
SESSION 27 SCHEDULE | |
Wednesday
SESSION 27:
IN HONOR OF ROY K. GREENBERG, MD: MORE ABOUT TAAAs: OPEN SURGERY, CHIMPS, FENESTRATED AND BRANCHED (F/B) ENDOGRAFTS
Moderators:Frank J. Veith, MD / Piergiorgio Cao, MD, FRCS
|
|
x | |
8:20 AM - 8:25 AM | New Strategies For Open Treatment Of TAAAs Including Sutureless Revascularization Of Renal Arteries Using A Novel Hybrid Graft And Other Techniques |
Presenter(s):Roberto Chiesa, MD / Germano Melissano, MD | |
View Abstract | |
8:26 AM - 8:31 AM | Why Do TAAAs In Young Patients With Connective Tissue Disorders Still Require Open Surgery And Are There Differences Between Degenerative And Post Dissection TAAAs That Should Influence Treatment |
Presenter(s):Michael J. Jacobs, MD / Geert Willem H. Schurink, MD, PhD | |
View Abstract | |
8:32 AM - 8:37 AM | DEBATE: Fenestrated And Branched F/B EVAR Is The Best And Most Durable Treatment For Pararenal And Thoracoabdominal Aneurysms |
Presenter(s):Matthew J. Eagleton, MD | |
View Abstract | |
8:38 AM - 8:43 AM | DEBATE: Outcomes Of Multiple Chimney And Periscope Grafts For Pararenal And Thoracoabdominal Aneurysms Are Equal To F/B Endografts And More Versatile |
Presenter(s):Mario Lachat, MD | |
View Abstract | |
8:44 AM - 8:49 AM | Mid-Term Outcomes And Technical Tips For Sandwich Endografts To Repair Pararenal And TAAAs: Are They Competitive With F/B Endografts |
Presenter(s):Armando C. Lobato, MD, PhD | |
View Abstract | |
8:50 AM - 8:55 AM | 2-Year Experience With An Off-The-Shelf Multibranched Endograft (T-Branched Graft From Cook) For TAAAs: Advantages And Limitations |
Presenter(s):Martin J. Austermann, MD / Theodosios Bisdas, MD / Konstantinos P. Donas, MD / Giovanni Torsello, MD | |
View Abstract | |
8:56 AM - 9:01 AM | DEBATE: Off-The-Shelf Endografts For Complex AAAs And TAAAs: They Are Up To The Job |
Presenter(s):Timothy A. Resch, MD, PhD | |
View Abstract | |
9:02 AM - 9:07 AM | DEBATE: Off-The-Shelf Endografts For Complex AAAs And TAAAs: They Are Not Ready For Wide Usage |
Presenter(s):Colin D. Bicknell, MD, FRCS | |
View Abstract | |
9:08 AM - 9:13 AM | Why I No Longer Use Surgeon-Modified Endografts For Complex AAAs And TAAAs: Advantages Of Industry-Made Endografts |
Presenter(s):Gustavo S. Oderich, MD, FACS | |
View Abstract | |
9:14 AM - 9:19 AM | Advantages And Limitations Of Internally Branched Endografts For Complex AAAs And TAAAs |
Presenter(s):Marcelo Ferreira, MD | |
View Abstract | |
9:20 AM - 9:28 AM | Panel Discussion |
9:28 AM - 9:40 AM | Break Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 27 | |
SESSION 28 SCHEDULE | |
Wednesday
SESSION 28:
MORE ABOUT PARALLEL GRAFTS AND F/B GRAFTS FOR AAAs, TAAAs AND COMPLICATIONS OF TBADs
Moderators:Matthew J. Eagleton, MD / James F. McKinsey, MD
|
|
x | |
9:40 AM - 9:45 AM | The Geppetto Technique To Avoid Brachial Access In Complex Endovascular Interventions Requiring Revascularization Of Multiple Branches |
Presenter(s):David J. Minion, MD | |
View Abstract | |
9:46 AM - 9:51 AM | The Nellix Endovascular Device Can Be Used With Multiple Chimneys For Juxta And Suprarenal AAAs And Ruptured AAAs: How To Do It |
Presenter(s):Ian Loftus, MD | |
View Abstract | |
9:52 AM - 9:57 AM | The Nellix Device Can Be Used To Treat Juxtarenal Elective And Ruptured AAAs By Employing Parallel Grafts To The Renal Arteries |
Presenter(s):Michel M.P. Reijnen, MD, PhD | |
View Abstract | |
9:58 AM - 10:03 AM | Gore Hybrid Grafts To Facilitate Visceral Debranching In Complex Hybrid Aortic Aneurysm Repairs |
Presenter(s):Sebastian E. Debus, MD, PhD | |
View Abstract | |
10:04 AM - 10:09 AM | The Gutter Killer: A New Catheter For Embolization Of Gutter Endoleaks In Parallel Grafts |
Presenter(s):Martin Malina, MD, PhD | |
View Abstract | |
10:10 AM - 10:15 AM | What Are Frequently Encountered Problems With F/B Endografts: How Can They Be Prevented And Corrected |
Presenter(s):Tara M. Mastracci, MD | |
View Abstract | |
10:16 AM - 10:23 AM | Panel Discussion |
Moderator(s): Jerry Goldstone, MD, FACS, FRCSEd / Mario Lachat, MD | |
10:24 AM - 10:29 AM | Mid-Term Outcomes Of Sandwich Grafts For Revascularizing Hypogastric Arteries With Common Iliac Aneurysms |
Presenter(s):Armando C. Lobato, MD, PhD | |
View Abstract | |
10:30 AM - 10:35 AM | Parallel Grafts (Chimney Or Periscope Grafts) Can Be Used To Revascularize A Critical IMA During EVAR Treatment Of AAAs |
Presenter(s):Ross Milner, MD | |
View Abstract | |
10:36 AM - 10:41 AM | Technique For Placing Guiding Sheaths, Stents And Stent-Grafts Into Visceral Arteries For Parallel Graft Procedures Complicated By Extreme Tortuosity Or Previous Hardware: How An Aortic Balloon Can Help |
Presenter(s):Jeffrey Y. Wang, MD | |
View Abstract | |
10:42 AM - 10:47 AM | Parallel Grafts (CHIMPS) For Revascularizing Vital Aortic Branches At All Levels Are Effective: What Is Their Value And Their Limitation |
Presenter(s):Chang Shu, MD | |
View Abstract | |
10:48 AM - 10:53 AM | Mid And Long-Term Results With Parallel Grafts (CHIMPS) In Complex AAA Repairs: How Good Are They |
Presenter(s):Alan M. Graham, MD | |
View Abstract | |
10:54 AM - 10:59 AM | A Side-By-Side Computational Flow Dynamic Analysis Of The Various Devices Used For Thoracoabdominal Aneurysm |
Presenter(s):Patrick W. Kelly, MD / Tyler Remund, PhD / Stephen Gent, PhD | |
View Abstract | |
11:00 AM - 11:06 AM | Panel Discussion |
END OF SESSION 28 | |
SESSION 29 SCHEDULE | |
Wednesday
SESSION 29:
A TRIBUTE TO OUR MILITARY (8 AND 9-MINUTE TALKS)
Moderators:Eric Elster, MD / Todd E. Rasmussen, MD, FACS
|
|
x | |
11:07 AM - 11:16 AM | The Doolittle Raiders And 30 Seconds Over Tokyo: What Did Their Skill And Courage Do For The US In World War II |
Presenter(s):Wayne F. Yakes, MD | |
View Abstract | |
11:17 AM - 11:25 AM | Lessons Learned From Treating Combat Casualties In Our Operations In Iraq And Afghanistan |
Presenter(s):Todd E. Rasmussen, MD, FACS | |
View Abstract | |
11:26 AM - 11:34 AM | Early Treatment Of Pediatric Vascular Injuries And Mass Casualties: Experience During Humanitarian Surgical Care During US Military Operations In Iraq And Afghanistan |
Presenter(s):Charles J. Fox, MD, FACS | |
View Abstract | |
11:35 AM - 11:43 AM | Recent Progress In Treating Major Vascular War Wounds |
Presenter(s):Eric Elster, MD | |
View Abstract | |
11:44 AM - 11:53 AM | What Biomedical Research That Is Important To All Of Us Is Being Conducted Aboard The International Space Station |
Presenter(s):Lee M. Morin, MD, PhD | |
View Abstract | |
11:54 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 29 | |
SESSION 30 SCHEDULE | |
Wednesday
SESSION 30:
NEW CONCEPTS, DIFFERING VIEWPOINTS, CONTROVERSIES IN VASCULAR DISEASE AND ITS TREATMENT
Moderators:Enrico Ascher, MD / Herbert Dardik, MD
|
|
x | |
1:00 PM - 1:05 PM | Appropriate Genome-Based Antiplatelet Treatment Should Be A Prerequisite For All Interventional Treatments |
Presenter(s):Karthikeshwar Kasirajan, MD | |
View Abstract | |
1:06 PM - 1:11 PM | Combined Anatomic-Functional Testing With Coronary CT Angiography And Functional Flow Dynamics Is A Game Changer In Evaluating Cardiac Status In Vascular Patients: It Will Replace All Other Diagnostic Tests |
Presenter(s):Christopher K. Zarins, MD | |
View Abstract | |
1:12 PM - 1:17 PM | Value Of Biomarkers For Arteriosclerosis In Predicting Cardiac Risk In Vascular Patients |
Presenter(s):Peter Henke, MD | |
View Abstract | |
1:18 PM - 1:23 PM | Monocyte Phenotyping: A Sensitive Biomarker For Predicting Adverse Vascular Events |
Presenter(s):John P. Fletcher, MD | |
View Abstract | |
1:24 PM - 1:29 PM | Update On The RCT Of Venous Balloon Angioplasty Of Venous Balloon Angioplasty vs. Venography Placebo: What Does It Tell Us |
Presenter(s):L. Nelson Hopkins, MD | |
View Abstract | |
1:30 PM - 1:35 PM | What Is SPY Technology And How Can It Help Vascular Specialists And Vascular Patients |
Presenter(s):Wei Zhou, MD | |
View Abstract | |
1:36 PM - 1:41 PM | DEBATE: Off Label Use Of EVAR Devices Leads To Higher Failure Rates |
Presenter(s):Andres Schanzer, MD | |
View Abstract | |
1:42 PM - 1:47 PM | DEBATE: Not So! Off-Label Use Of Newer EVAR Devices Does Not Lead To Higher Failure Rates: Why The Discrepancy |
Presenter(s):B. Patrice Mwipatayi, FRACS | |
View Abstract | |
1:48 PM - 1:53 PM | Saccular AAAs Behave Differently From Fusiform AAAs Of The Same Diameter: How Should It Influence Our Treatment: Is There Proof |
Presenter(s):Jacques Busquet, MD | |
View Abstract | |
1:54 PM - 1:59 PM | DEBATE: How Far Should We Go With Endovascular Treatment Of Challenging CTOs Causing CLI: An Interventionalists Point Of View |
Presenter(s):Craig M. Walker, MD | |
View Abstract | |
2:00 PM - 2:05 PM | DEBATE: How Far Should We Go With Endovascular Treatment Of Challenging CTOs Causing CLI: An Endocompetent Vascular Surgeons View |
Presenter(s):Bruce A. Perler, MD, MBA | |
View Abstract | |
2:06 PM - 2:13 PM | Panel Discussion |
END OF SESSION 30 | |
SESSION 31 SCHEDULE | |
Wednesday
SESSION 31:
NEW DATA ON MULTILAYER FLOW MODULATING (MLFM) BARE STENTS IN THE TREATMENT OF ANEURYSMS AND DISSECTIONS
Moderators:Frank J. Veith, MD / Edward B. Diethrich, MD
|
|
x | |
2:13 PM - 2:18 PM | Update On The Value Of MLFM Uncovered Stents In The Treatment Of Visceral And Popliteal Aneurysms: Do They Shrink: Have Any Ruptured |
Presenter(s):Claudio Rabbia, MD / Maria Antonella Ruffino, MD | |
View Abstract | |
2:19 PM - 2:24 PM | Endovascular Treatment Of Complex Thoracic Aortic Aneurysm With Multiple Overlapping Bare Stents Can Decrease Spinal Cord Ischemia (SCI) And Result In Decreased Aneurysm Size: When Is This Treatment Appropriate |
Presenter(s):Qingsheng Lu, MD / Zaiping Jing, MD | |
View Abstract | |
2:25 PM - 2:30 PM | Continuing Impressions Of The Value Of MLFM Bare Stents In Treating Complex Aortic Aneurysms |
Presenter(s):Edward B. Diethrich, MD | |
View Abstract | |
2:31 PM - 2:36 PM | Mechanisms Whereby MLFM Bare Stents Could Prevent Aneurysm Rupture: Do They Work |
Presenter(s):Jean-Marc Alsac, MD, PhD | |
View Abstract | |
2:37 PM - 2:42 PM | Brazilian Experience With MLFM Stents In The Treatment Of Aortic Aneurysms |
Presenter(s):Daniel Benitti, MD | |
View Abstract | |
2:43 PM - 2:48 PM | 3-Year Results Of The French Registry Of MLFM Stents In The Treatment Of Thoracic And Abdominal Complex Aortic Aneurysms |
Presenter(s):Claude D. Vaislic, MD | |
View Abstract | |
2:49 PM - 2:54 PM | Value And Limitations Of The MLFM Stent In Treating Arch Aneurysms And Dissections |
Presenter(s):Erno Remsey-Semmelweis, MD, PhD | |
View Abstract | |
2:55 PM - 3:00 PM | Pros And Cons Of MLFM Stents For The Treatment Of Complex Aortic Aneurysms: A Balanced View And Is Sac Thrombosis Good Or Bad For Aneurysm Wall Integrity And Rupture: What Is The Mechanism |
Presenter(s):Frans L. Moll, MD, PhD | |
View Abstract | |
3:01 PM - 3:06 PM | Advantages And Limitations Of MLFM Stents For Aortic Aneurysm Treatment: When Do They Work And When Dont They: Results Of The German Registry |
Presenter(s):Ralf R. Kolvenbach, MD | |
View Abstract | |
3:07 PM - 3:12 PM | DEBATE: The MLFM Device Is A Disruptive Technology For Aortic Aneurysm And Dissection Based On The Results Of A Global Registry |
Presenter(s):Sherif Sultan, MD, FRCS, EBQS-VASC | |
View Abstract | |
3:13 PM - 3:18 PM | DEBATE: MLFM Stents Are Not An Effective Treatment For Complex Aortic Aneurysm And Do Not Prevent Sac Growth And Rupture |
Presenter(s):Thomas Larzon, MD, PhD | |
View Abstract | |
3:19 PM - 3:29 PM | Panel Discussion |
3:30 PM - 3:40 PM | Break Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 31 | |
SESSION 32 SCHEDULE | |
Wednesday
SESSION 32:
NEW DEVELOPMENTS IN ROBOTICS, ENDOVASCULAR GUIDANCE, ENDOSCOPY ACCESS AND OTHER IMPROVED TECHNOLOGY
Moderators:Alan B. Lumsden, MD, FACS / Nicholas J.W. Cheshire, MD
|
|
x | |
IMPROVED ROBOTIC GUIDANCE | |
3:40 PM - 3:45 PM | Experience With Improved Lower Profile Robotic Catheter Techniques: They Facilitate Many Endovascular Procedures Including Complex Embolizations |
Presenter(s):Barry T. Katzen, MD | |
View Abstract | |
3:46 PM - 3:51 PM | How Can Robotic Navigation Be Combined With 3D Imaging To Make Complex Endovascular Procedures Easier, Quicker And More Predictable With Complex Anatomy: How Does the 6 French System Help |
Presenter(s):Alan B. Lumsden, MD, FACS | |
View Abstract | |
3:52 PM - 3:57 PM | How Can Robotic Assistance And Guidance Be Helpful With Complex Anatomy For CAS And F/B EVAR: What About Radiation Exposure |
Presenter(s):Nicholas J.W. Cheshire, MD / Celia Riga, MD | |
View Abstract | |
3:58 PM - 4:03 PM | What Does The ROVER Registry Tell Us About Advantages Of Robotic Catheter Based Procedures: Faster, Less Arterial Wall Trauma, Decreased Radiation Exposure, Improved Crossing Of Difficult CTOs |
Presenter(s):Jean Bismuth, MD | |
View Abstract | |
4:04 PM - 4:09 PM | Minimally Invasive Treatment Of Paget-Schroetter Disease With EKOS Ultrasound Assisted Thrombolysis And Robot Assisted First Rib Resection: How The Robot Helps |
Presenter(s):Hans M.E. Coveliers, MD, MBA | |
View Abstract | |
4:10 PM - 4:15 PM | The Truth About Endoscopic Vein Harvest: Is It Worthwhile: Based On VQI Observations |
Presenter(s):Fred A. Weaver, MD | |
View Abstract | |
4:16 PM - 4:21 PM | Tips And Tricks For Radial Access For Lower Extremity And Other Remote Lesion Treatments: Equipment Required |
Presenter(s):Marcelo Guimaraes, MD | |
View Abstract | |
4:22 PM - 4:27 PM | Update With New Simplified Aortic Occlusion Balloon For Ruptured AAAs And Other Hemorrhagic Emergencies: Advantages, Limitations And Clinical Experience: Scoring System To Help Tell Us Which Ruptured AAAs Should Not Be Treated |
Presenter(s):Benjamin W. Starnes, MD | |
View Abstract | |
4:28 PM - 4:33 PM | When Can Improved Duplex Ultrasound Replace Contrast CTA For Post-EVAR Surveillance And Detecting Failing Lower Extremity Stent-Grafts |
Presenter(s):Keith D. Calligaro, MD | |
View Abstract | |
4:34 PM - 4:40 PM | Panel Discussion |
END OF SESSION 32 | |
SESSION 33 SCHEDULE | |
Wednesday
SESSION 33:
NEW DEVELOPMENTS IN THE TREATMENT OF RUPTURED AAAs
Moderators:Benjamin W. Starnes, MD / Matt M. Thompson, MD
|
|
x | |
4:40 PM - 4:45 PM | 100% Of Ruptured AAAs (RAAAs) Can Be Treated Endovascularly If Chimney, Periscopes And Other Adjuncts Are Used: Turn-Down Rates Are Low And Early Mortality Is Low |
Presenter(s):Dieter O. Mayer, MD / Thomas Larzon, MD, PhD / Mario Lachat, MD | |
View Abstract | |
THE RECENT RCTS OF RAAAS: FACTS AND FLAWS A MEGA DEBATE | |
4:46 PM - 4:51 PM | Results From The French ECAR RCT Results Comparing EVAR With Open Repair For RAAAs |
Presenter(s):Pascal Desgranges, MD, PhD | |
View Abstract | |
4:52 PM - 4:57 PM | Results From The Dutch AJAX RCT Comparing EVAR With Open Repair For RAAAs |
Presenter(s):Willem Wisselink, MD | |
View Abstract | |
4:58 PM - 5:03 PM | Early Results From The UK IMPROVE Trial Comparing An EVAR Strategy With Open Repair For RAAAs: It Shows That The EVAR Strategy Has No Lower Early Mortality Than Open Repair |
Presenter(s):Janet T. Powell, MD, PhD | |
View Abstract | |
WHY THE RCTS ARE MISLEADING | |
5:04 PM - 5:09 PM | IMPROVE Trial Is A Laudable Study, But Its Conclusion Is Flawed: EVAR Is Better Than Open Repair For RAAAs |
Presenter(s):Frank J. Veith, MD | |
View Abstract | |
5:10 PM - 5:15 PM | The 3 Recent RAAA RCTs Are Flawed And Misleading: What Are These Flaws |
Presenter(s):Nicholas J.W. Cheshire, MD | |
View Abstract | |
5:16 PM - 5:21 PM | EVAR Is Clearly Better Than Open Repair And We Do Not Need An RCT To Prove It |
Presenter(s):Mario Lachat, MD | |
View Abstract | |
5:22 PM - 5:27 PM | The Recent RCTs Comparing EVAR To Open Repair For RAAAs Are Misleading And We Do Not Need More RCTs To Prove EVAR Is Better |
Presenter(s):Thomas Larzon, MD, PhD | |
View Abstract | |
OTHER OPINIONS AND DATA | |
5:28 PM - 5:33 PM | EVAR Clearly Should Be The First Treatment Choice For RAAAs: We Dont Need More Trials To Prove It |
Presenter(s):Edward B. Diethrich, MD / Julio A. Rodriguez-Lopez, MD | |
View Abstract | |
5:34 PM - 5:39 PM | Does A Fixed Protocol For Treating Ruptured AAAs By EVAR Improve Outcomes: Based On A Prospective Multicenter Registry Results |
Presenter(s):Kim J. Hodgson, MD | |
View Abstract | |
5:40 PM - 5:45 PM | Meta-Analysis Of Recent RCTs Comparing EVAR With Open Repair For Ruptured AAAs: It Is Level 1A Evidence, But It May Be Misleading |
Presenter(s):Ron Balm, MD, PhD | |
View Abstract | |
5:46 PM - 5:51 PM | Long-Term Survival Of Ruptured AAAs Is Better After EVAR Than After Open Repair: The Early Survival Benefit Of EVAR Persists Beyond 5 Years |
Presenter(s):Dieter O. Mayer, MD / Mario Lachat, MD / Frank J. Veith, MD / Zoran Rancic, MD, PhD | |
View Abstract | |
5:52 PM - 5:57 PM | Why Are Treatment Outcomes For RAAAs Better In The US Than In The UK: Hints For Improving Results And Support For The Position That EVAR Is Better Than Open Repair |
Presenter(s):Matt M. Thompson, MD | |
View Abstract | |
5:58 PM - 6:08 PM | Panel Discussion End of Program D |
END OF SESSION 33 | |
SESSION 34 SCHEDULE | |
Wednesday
SESSION 34:
NEW FINDINGS AND INFORMATION ON THE TREATMENT OF POPLITEAL ANEURYSM
Moderators:Enrico Ascher, MD / Barry T. Katzen, MD
|
|
x | |
6:45 AM - 6:50 AM | What Are The Real Results Of Endovascular Popliteal Aneurysm Repair: When Is It Indicated And When Contraindicated |
Presenter(s):Sonia Ronchey, MD, PhD | |
View Abstract | |
6:51 AM - 6:56 AM | Anatomic Features That Predict Complications Of Endovascular Aneurysm Repair And When It Is Contraindicated |
Presenter(s):Thomas L. Forbes, MD | |
View Abstract | |
6:57 AM - 7:02 AM | The Modern Treatment Of Popliteal Aneurysms Varies Widely: Why Is This So: Value Of Thrombolysis: What Is The Best Surgical Approach |
Presenter(s):Martin Bjorck, MD, PhD | |
View Abstract | |
7:03 AM - 7:08 AM | Long-Term Outcomes And Sac Shrinkage After Endovascular Popliteal Aneurysm Repair: What Are The Implications |
Presenter(s):Franco Grego, MD / Giovanni P. Deriu, MD | |
View Abstract | |
7:09 AM - 7:14 AM | Avoidance And Treatment Of Complications After Endografting For Popliteal Aneurysm |
Presenter(s):Irwin V. Mohan, MBBS, MD, FRCS, FEBVS, FRACS | |
View Abstract | |
7:15 AM - 7:20 AM | Popliteal Aneurysm Treatment: When Endo, When Open: Technical Tips: Primary And Secondary Patency Results; Reintervention Is Not Always Required For Graft Failure |
Presenter(s):Neal S. Cayne, MD | |
View Abstract | |
THREE-PART DEBATE | |
7:21 AM - 7:26 AM | DEBATE: Endovascular Treatment Is Inferior For Popliteal Aneurysms Needing Treatment |
Presenter(s):Werner Lang, MD | |
View Abstract | |
7:27 AM - 7:32 AM | DEBATE: Some Popliteal Aneurysms Should Be Treated Endo; Some Open |
Presenter(s):Bauer E. Sumpio, MD, PhD | |
View Abstract | |
7:33 AM - 7:38 AM | DEBATE: Almost All Popliteal Aneurysms Can Be Treated Endovascularly: Technical Considerations And Outcomes: What Was The Outcome Of The Former Vice President's Large Popliteal Aneurysm Repairs In 2004 |
Presenter(s):Barry T. Katzen, MD | |
View Abstract | |
7:39 AM - 7:44 AM | Panel Discussion |
END OF SESSION 34 | |
SESSION 35 SCHEDULE | |
Wednesday
SESSION 35:
NEW DEVELOPMENTS IN THE TREATMENT OF INFECTED AORTIC GRAFTS AND ENDOGRAFTS; VALUE OF EVAR FOR MYCOTIC ANEURYSMS
Moderators:Dennis F. Bandyk, MD / Keith D. Calligaro, MD
|
|
x | |
7:45 AM - 7:50 AM | Update On Silver/Triclosan Synergy Prosthesis For In Situ Replacement Of Infected Aortic Prostheses: They Really Work Based On The SATIGI Registry And Other Data |
Presenter(s):Max Zegelman, MD | |
View Abstract | |
7:51 AM - 7:56 AM | Endovascular Treatment Of Mycotic AAAs: When Does It Work And For How Long: Based On 132 Cases With Long Follow-up |
Presenter(s):Anders Wanhainen, MD, PhD | |
View Abstract | |
7:57 AM - 8:02 AM | When Are Endografts The Best Treatment For Aortic Infection And When Are They Not |
Presenter(s):Francesco Setacci, MD | |
View Abstract | |
8:03 AM - 8:08 AM | Conservative Treatment Of Endograft Infection After EVAR With CT Guided Drainage And Graft Preservation: When Can It Work And When Can It Not |
Presenter(s):Kamphol Laohapensang, MD | |
View Abstract | |
8:09 AM - 8:14 AM | Treatment Of Para And Suprarenal Aortic Graft Infection: Do Endografts Play A Role |
Presenter(s):Manju Kalra, MBBS | |
View Abstract | |
8:15 AM - 8:20 AM | Technical Tips For Removing An Infected Endograft: It Is Not Simple |
Presenter(s):Thomas C. Bower, MD | |
View Abstract | |
8:21 AM - 8:26 AM | EVAR Can Be Effective Treatment For Infected Aneurysms In All Parts Of The Aorta With Both Simple And Complex Anatomies: Chimney Grafts May Be Needed: How To Do It Successfully And Get Long-Term Survival |
Presenter(s):Boonprasit Kritpracha, MD | |
View Abstract | |
8:27 AM - 8:32 AM | DEBATE: Management Of Mycotic Aneurysms And Infected Stent-Grafts After EVAR And TEVAR: Infected Endografts Must Come Out |
Presenter(s):Piotr M. Kasprzak, MD | |
View Abstract | |
8:33 AM - 8:38 AM | DEBATE: Not So: A New Treatment Paradigm For Treating Infected Endografts After EVAR And Mycotic Aneuryms May Allow Endograft Preservation |
Presenter(s):Martin Malina, MD, PhD | |
View Abstract | |
8:39 AM - 8:44 AM | How To Treat Mycotic Thoracic Aneurysms |
Presenter(s):Roberto Chiesa, MD / Germano Melissano, MD | |
View Abstract | |
8:45 AM - 8:52 AM | Panel Discussion |
END OF SESSION 35 | |
SESSION 36 SCHEDULE | |
Wednesday
SESSION 36:
EXCITING NEW DEVELOPMENTS IN THE MEDICAL TREATMENT OF VASCULAR DISEASE
Moderators:Russell H. Samson, MD, RVT, FACS / Frans L. Moll, MD, PhD
|
|
x | |
8:52 AM - 8:57 AM | Do Atherosclerotic Plaques Regress: How And Why: What Are The Implications For Treatment |
Presenter(s):Ralph G. DePalma, MD | |
View Abstract | |
8:58 AM - 9:03 AM | How Can The Medical Treatment Of Arteriosclerosis Be Improved: Should More Patients Receive Statins: Do HDL Levels Matter: Does Elevating A Low HDL Level Help In Any Way: What Is On The Horizon For Improving Drug Or Medical Treatment For Arteriosclerosis |
Presenter(s):Don Poldermans, MD | |
View Abstract | |
9:04 AM - 9:09 AM | What Do The New AHA Cholesterol Guidelines And The New Information About Beta Blockers Mean To Vascular Surgeons |
Presenter(s):Peter Henke, MD | |
View Abstract | |
9:10 AM - 9:15 AM | Medical Therapy In Peripheral Artery Disease: Anything New On The Horizon: What Is The Value Of Chronic PA Pressure Monitoring With The CardioMEMS Implantable Pressure Sensor |
Presenter(s):Jeffrey S. Berger, MD, MS, FAHA, FACC | |
View Abstract | |
9:16 AM - 9:21 AM | Why All Vascular Patients Should Have Perioperative Or Periprocedural Troponins: How Do They Help In Patient Treatment |
Presenter(s):Jeffrey S. Berger, MD, MS, FAHA, FACC | |
View Abstract | |
9:22 AM - 9:27 AM | How Long Should Dual Antiplatelet Treatment Be Continued After Patients Receive A Coronary Stent (BMS Or DES): When Is It Safe To Stop Clopidogrel And Perform Non-Cardiac Surgery An AAA, A Leg Bypass Or CEA: What To Do If Surgery Cannot Be Delayed: Based On New Findings From The OPTIMIZE Trial |
Presenter(s):Ron Waksman, MD | |
View Abstract | |
9:28 AM - 9:33 AM | Vitamin D Supplementation And Tight Blood Glucose Control In Diabetics Do Not Have A Major Impact On The Progression Of Vascular Disease: Other Factors Are More Important |
Presenter(s):Erich Minar, MD | |
View Abstract | |
9:34 AM - 9:39 AM | How To Prevent And Treat Postoperative Delirium After Vascular Surgery |
Presenter(s):Clark J. Zeebregts, MD, PhD | |
View Abstract | |
9:40 AM - 9:47 AM | Panel Discussion |
9:48 AM - 10:00 AM | Break Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 36 | |
SESSION 37 SCHEDULE | |
Wednesday
SESSION 37:
NEW DEVELOPMENTS IN ENDOVASCULAR TECHNOLOGY, TECHNIQUES AND THE MEDICAL TREATMENT OF VASCULAR DISEASE
Moderators:Alan B. Lumsden, MD, FACS / Richard J. Powell, MD
|
|
x | |
10:00 AM - 10:05 AM | Imaging With Lower Radiation Exposure Using A Novel Fixed C-Arm System During Endovascular Procedures: The Philips Allura Clarity Hybrid OR |
Presenter(s):Olivier H.J. Koning, MD | |
View Abstract | |
10:06 AM - 10:11 AM | Unusual Uses Of Re-entry Devices: They Are An Essential Tool |
Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR | |
View Abstract | |
10:12 AM - 10:17 AM | DEBATE: Be Skeptical About The Need For Atherectomy Systems: The New Ones May Be No Better Than The Old Ones |
Presenter(s):Frank J. Criado, MD, FACS, FSVM | |
View Abstract | |
10:18 AM - 10:23 AM | DEBATE: Not So Fast, Leaving Nothing Behind Trumps Any Permanent Device In The SFA: Current Evidence And Clinical Utility Of Atherectomy Systems |
Presenter(s):Lawrence A. Garcia, MD | |
View Abstract | |
10:24 AM - 10:29 AM | Endovenous Or Perivascular Routes For Internal Prosthetic Bypasses In The SFA And Popliteal Arteries: How Can IVUS And Robotics Help: A New Treatment Concept |
Presenter(s):Alan B. Lumsden, MD, FACS / Tony S. Das, MD | |
View Abstract | |
10:30 AM - 10:35 AM | Where Do We Stand With Cell Therapy For Ischemia In The Legs; In The Heart |
Presenter(s):Alan Dardik, MD, PhD | |
View Abstract | |
10:36 AM - 10:41 AM | Tips And Tricks For Endovascular Interventions In Pediatric Patients |
Presenter(s):Furuzan Numan, MD | |
View Abstract | |
10:42 AM - 10:47 AM | Manifestations And Treatment Of Spontaneous Renal Artery Dissections |
Presenter(s):James C. Stanley, MD | |
View Abstract | |
10:48 AM - 10:57 AM | Panel Discussion |
NEW DEVELOPMENTS IN MEDICAL TREATMENT AND RISK MODIFICATION | |
Moderator(s): Ron Waksman, MD / Jack L. Cronenwett, MD | |
10:57 AM - 11:02 AM | How To Improve 5-Year Survival After Vascular Surgery By 25% Or More: Give Proper Doses Of Statins And Antiplatelet Agents |
Presenter(s):Jack L. Cronenwett, MD | |
View Abstract | |
11:03 AM - 11:08 AM | Preoperative Statin Administration Decreases The Incidence Of Contrast Induced Kidney Injury |
Presenter(s):John H. Rundback, MD, FSIR, FAHA | |
View Abstract | |
11:09 AM - 11:14 AM | A Frailty Index And What It Can Mean For Vascular Specialists Or Surgeons Interested In Vascular Disease Patients: Is It Better Than The Eyeball Test |
Presenter(s):Gregory L. Moneta, MD | |
View Abstract | |
11:15 AM - 11:20 AM | Differential Effect Of Arteriosclerotic Risk Factors In Men And Women: Why Does It Matter |
Presenter(s):Caron B. Rockman, MD | |
View Abstract | |
11:21 AM - 11:26 AM | Cilostazol Is Associated With Improved Outcomes After Vascular Interventions: Should Vascular Specialists Use It And How |
Presenter(s):Richard J. Powell, MD | |
View Abstract | |
11:27 AM - 11:32 AM | What Test Should We Use To Evaluate Antiplatelet Drugs In Vascular Patients Especially Those Undergoing A Procedure |
Presenter(s):Frans L. Moll, MD, PhD | |
View Abstract | |
11:33 AM - 11:38 AM | Importance Of Smoking Cessation Prior To Lower Extremity Bypasses: It Decreases The Failure Rate |
Presenter(s):Christopher J. Abularrage, MD / James H. Black III, MD | |
View Abstract | |
11:39 AM - 11:44 AM | How To Prevent Cardiovascular Death In Diabetic Patients With CLI And Arteriosclerosis: It Is As Important As Saving The Limb |
Presenter(s):Francesco Liistro, MD | |
View Abstract | |
11:45 AM - 11:50 AM | Characteristics Of Patients Who Currently Develop Acute Limb Ischemia And What Is Their Long-Term Prognosis |
Presenter(s):Beatrice R. Amann-Vesti, MD | |
View Abstract | |
11:51 AM - 0:00 AM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 37 | |
SESSION 38 SCHEDULE | |
Wednesday
SESSION 38:
ADVANCES IN IMAGING
Moderators:Barry T. Katzen, MD / Henrik Sillesen, MD, DMSc
|
|
x | |
1:00 PM - 1:05 PM | Selective Intra-Arterial CTA For Lower Extremity Occlusive Disease In Patients With Renal Insufficiency: It Decreases Contrast Dose And Is Safe |
Presenter(s):Anders Wanhainen, MD, PhD | |
View Abstract | |
1:06 PM - 1:11 PM | Advantages Of An Integrated 3-D Imaging Solution For Planning, Fusion And Assessment Of Complex Aortic Procedures |
Presenter(s):Stephan Haulon, MD | |
View Abstract | |
1:12 PM - 1:17 PM | Aortic Procedures Of The Future Will Mandate 3D Imaging For Planning And Preparation, And For Performing |
Presenter(s):Dittmar Boeckler, MD | |
View Abstract | |
1:18 PM - 1:23 PM | The Use Of A Computerized Patient Specific Model And MRA Data To Predict Pressure Drops Across Equivocal Stenoses |
Presenter(s):Jean-Paul de Vries, MD, PhD | |
View Abstract | |
1:24 PM - 1:29 PM | Precannulation Of Visceral And Renal Arteries Using Fusion Software On The Artis Zeego System During F/B EVAR Is Fast, Simple, And Valuable: How To Do It |
Presenter(s):Neal S. Cayne, MD | |
View Abstract | |
1:30 PM - 1:35 PM | Value And Implementation Of 3D Ultrasound Scans For All AAA Evaluations: What Can And Should Be Measured: What Equipment Is Needed |
Presenter(s):Henrik Sillesen, MD, DMSc | |
View Abstract | |
1:36 PM - 1:41 PM | 3D Ultrasound Is The CT Scan Of The Future And Eliminates Radiation Exposure |
Presenter(s):Brajesh K. Lal, MD | |
View Abstract | |
1:42 PM - 1:47 PM | What New Information Can Be Learned From 3D Ultrasound Of AAAs: How Can It Provide Finite Element Analysis |
Presenter(s):Marc R.H.M. van Sambeek, MD, PhD | |
View Abstract | |
1:48 PM - 1:53 PM | Panel Discussion |
1:54 PM - 1:59 PM | What Important Information Can Be Obtained From Transcranial Doppler (TCD) If You Know How To Get It: Wider Use Of TCD Is Justified |
Presenter(s):Zsolt Garami, MD | |
2:00 PM - 2:05 PM | 3D Holography To Guide Endovascular Interventions: How Does It Work: Can CTA Be Avoided And MRI And 3D Ultrasound Take Its Place |
Presenter(s):Elchanan Bruckheimer, MBBS | |
View Abstract | |
2:06 PM - 2:11 PM | A Complete Mobile Hybrid Room With Ziehm Vision RFD Hybrid C-Arm And Stille Imagiq2 Floating Table For Complex Endovascular Procedures: Advantages And Limitations Compared To A Fixed Hybrid Room |
Presenter(s):Peter C.J. Goverde, MD | |
View Abstract | |
2:12 PM - 2:17 PM | DEBATE: Should Duplex Ultrasound Replace CTA For Post EVAR Surveillance: YES, In Most Cases |
Presenter(s):Michel Makaroun, MD | |
View Abstract | |
2:18 PM - 2:23 PM | DEBATE: Should Duplex Ultrasound Replace CTA For Post EVAR Surveillance: NO, In Most Cases |
Presenter(s):S. Rao Vallabhaneni, MD, FRCS | |
View Abstract | |
2:24 PM - 2:29 PM | Panel Discussion |
END OF SESSION 38 | |
SESSION 39 SCHEDULE | |
Wednesday
SESSION 39:
ADVANCES AND UPDATES IN THE TREATMENT OF THORACIC OUTLET SYNDROMES, AN HISTORICAL VIGNETTE AND NEW DEVICES AND CONCEPTS
Moderators:R. Clement Darling III, MD / Julie Ann Freischlag, MD
|
|
x | |
2:29 PM - 2:34 PM | New Thoracic Outlet Syndrome (TOS) SVS Reporting Standards: What Is New |
Presenter(s):Karl A. Illig, MD | |
View Abstract | |
2:35 PM - 2:40 PM | Treatment Of TOS And Popliteal Entrapment In High Performance Athletes: What Is The Role Of Exercise, Physiotherapy And Surgery |
Presenter(s):Jason T. Lee, MD | |
View Abstract | |
2:41 PM - 2:46 PM | Some Patients With Presumed Neurogenic TOS Really Have Jugular And Subclavian Venous Stenosis: Balloon Angioplasty Can Provide Symptom Relief |
Presenter(s):Sam S. Ahn, MD, FACS, MBA | |
View Abstract | |
2:47 PM - 2:52 PM | Current Optimal Treatment For Arterial Compression At The Thoracic Outlet |
Presenter(s):Enrique Criado, MD, FACS | |
View Abstract | |
2:53 PM - 2:58 PM | Historical Vignette: The First Endoleak And The First AAA Repair By Norman Freeman Before Charles Dubosts |
Presenter(s):Christopher K. Zarins, MD | |
View Abstract | |
2:59 PM - 3:04 PM | Infrared IVUS: A New Technique For Detecting Vulnerable Plaque |
Presenter(s):Ron Waksman, MD | |
View Abstract | |
3:05 PM - 3:10 PM | Early Experience With A New Improved Digital Mobile C-Arm: The Cios Alpha System From Siemens: Advantages And Limitations |
Presenter(s):Sebastian E. Debus, MD, PhD | |
View Abstract | |
3:11 PM - 3:16 PM | Panel Discussion |
3:17 PM - 3:30 PM | Break Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 39 | |
SESSION 40 SCHEDULE | |
Wednesday
SESSION 40:
NEW CONCEPTS, TECHNIQUES, UPDATES
Moderators:Christopher K. Zarins, MD / Amman Bolia, MD
|
|
x | |
3:30 PM - 3:35 PM | Value And Limitations Of Optical Coherence Tomography For Use In Lower Extremity Vascular Assessment And Treatments |
Presenter(s):Vikram S. Kashyap, MD | |
View Abstract | |
3:36 PM - 3:41 PM | Sensible And Extreme Approach To Limb Preservation (The SEAL Approach): Who And What Is Involved And What Are The Benefits: Should There Be SEAL Centers |
Presenter(s):Niten Singh, MD | |
View Abstract | |
3:42 PM - 3:47 PM | The Chocolate Balloon: A New Better Less Traumatic Drug Coated Balloon For Dilating Arterial Lesions With Less Dissection: Mode Of Action, Advantages And Clinical Experience |
Presenter(s):Jihad A. Mustapha, MD | |
View Abstract | |
3:48 PM - 3:53 PM | Does Prostate Endovascular Embolization Work: For What Conditions: Advantages And Limitations |
Presenter(s):Jφrn O. Balzer, MD, PhD | |
View Abstract | |
3:54 PM - 3:59 PM | Pathophysiology Of Hand And Finger Ischemia In Hemodialysis Patients And How It Can Best Be Treated |
Presenter(s):Roberto Ferraresi, MD | |
View Abstract | |
4:00 PM - 4:05 PM | Update On Tissue Engineered Arterial Prostheses: Progress And Remaining Challenges |
Presenter(s):Elliot L. Chaikof, MD, PhD | |
View Abstract | |
4:06 PM - 4:11 PM | For Recanalizing Lower Extremity CTOs Above And Below The Knee, Simpler And Cheaper Devices Are Better: It Does Not Matter Whether The Route Is Intraluminal Or Subintimal |
Presenter(s):Amman Bolia, MD | |
View Abstract | |
4:12 PM - 4:17 PM | Will DEBs Become The Gold Standard For Dilating Bare Metal Stents (BMSs) In The SFA: Will This Strategy Be Cost Effective |
Presenter(s):Stefan Mueller-Hόlsbeck, MD | |
View Abstract | |
4:18 PM - 4:23 PM | Current Optimal Techniques For Minimizing Contrast Induced Nephropathy After Angiographic Procedures |
Presenter(s):Jonathan R. Boyle, MD, FRCS | |
View Abstract | |
4:24 PM - 4:29 PM | Quantitative Determination Of Respiratory Movement Of Aorta And Side Branches In Image Fusion Guidance: How Can It Improve Branch Origin Location Accuracy And Minimize Errors |
Presenter(s):Geert Willem H. Schurink, MD, PhD | |
View Abstract | |
4:30 PM - 4:35 PM | Underutilization Of Statins In CLI Patients: Statins Keep The Patient Alive Longer And Decrease Amputation Rates After Open And Endo Revascularization Procedures |
Presenter(s):Todd R. Vogel, MD, MPH | |
View Abstract | |
4:36 PM - 4:41 PM | Diagnosis And Management Of Vascular Complications In Athletes |
Presenter(s):Jonathan D. Beard, ChM, MEd, FRCS | |
View Abstract | |
4:42 PM - 4:50 PM | Panel Discussion |
END OF SESSION 40 | |
SESSION 41 SCHEDULE | |
Wednesday
SESSION 41:
NEW CONCEPTS IN ENDOVASCULAR TREATMENT AND MANAGEMENT OF COMPLICATONS; MORE INFORMATION ABOUT RENAL DENERVATION AND OTHER WAYS TO TREAT RESISTANT HYPERTENSION; AMPUTATIONS
Moderators:Mark H. Wholey, MD / Krishna J. Rocha-Singh, MD
|
|
x | |
4:50 PM - 4:55 PM | We Dont Need More Endovascular Treatments: Just Better Use Of The Ones We Have |
Presenter(s):Manj S. Gohel, MD, FRCS | |
View Abstract | |
4:56 PM - 5:01 PM | AAA Wall Microvasculature: How Does It Relate To Thrombus Formation And AAA Growth |
Presenter(s):Geert Willem H. Schurink, MD, PhD | |
View Abstract | |
5:02 PM - 5:07 PM | Hypercoagulable Testing Is Far Overused In Vascular Patients Whose Revascularizations Fail Repeatedly: What Should We Do To Evaluate Such Patients And When Is Such Testing Helpful |
Presenter(s):Elna M. Masuda, MD | |
View Abstract | |
5:08 PM - 5:13 PM | A New Simple Technique For Perfusing The Lower Limb To Prevent Ischemia During Prolonged Sheath Obstruction Of The Femoral Arteries During F/B EVAR |
Presenter(s):Johannes Kalder, MD | |
View Abstract | |
5:14 PM - 5:19 PM | Total Percutaneous Axillary Artery Access In Complex Endovascular Aortic Repair: Technical Tips And Precautions |
Presenter(s):Barend M.E. Mees, MD, PhD | |
View Abstract | |
MORE TOPICS ON RESISTANT HYPERTENSION | |
5:20 PM - 5:25 PM | With Respect To Renal Denervation, Where Do The Renal Sympathetic Nerves Lie With Respect To The Renal Artery: Can Radiofrequency (RF) And Ultrasound Inactivate Them And What Effect Do These Modalities Have On The Renal Artery |
Presenter(s):Renu Virmani, MD | |
View Abstract | |
5:26 PM - 5:31 PM | Is An Arteriovenous Anastomosis The Way To Cure Resistant Hypertension: How Does It Work And Results Of The ROX Arteriovenous Coupler Trial |
Presenter(s):Melvin D. Lobo, MBChB, PhD, FRCP | |
View Abstract | |
5:32 PM - 5:37 PM | Percutaneous Creation Of An A-V Fistula With The ROX Device: Can It Treat Resistant Hypertension And Other Conditions |
Presenter(s):David H. Deaton, MD | |
View Abstract | |
5:38 PM - 5:43 PM | Is There A Role For Chemoablation For Renal Denervation |
Presenter(s):Mark H. Wholey, MD / Michael H. Wholey, MD, MBA | |
View Abstract | |
5:44 PM - 5:49 PM | Why The Negative Results Of SIMPLICITY III Are No Surprise: It Does Not Mean The Field Is Dead: Predictions For The Future |
Presenter(s):Mehdi H. Shishehbor, DO, MPH, PhD | |
View Abstract | |
5:50 PM - 6:00 PM | Panel Discussion End of Program E |
END OF SESSION 41 | |
SESSION 42 SCHEDULE | |
Wednesday
SESSION 42:
MANAGEMENT OF PULMONARY EMBOLISM: THE SPECTRUM AS IT EVOLVES DRUGS, DEVICES AND SURGERY PART 1
Moderators:Michael R. Jaff, DO
|
|
x | |
7:00 AM - 7:05 AM | Introduction To The Symposium |
Presenter(s):Frank J. Veith, MD | |
7:05 AM - 7:15 AM | Welcome And Introduction |
Presenter(s):Michael R. Jaff, DO | |
7:15 AM - 7:25 AM | The Basics Of Pulmonary Embolism: What Is The Role Of The History, Exam, Biomarkers |
Presenter(s):Ido Weinberg, MD, MSc | |
View Abstract | |
7:25 AM - 7:35 AM | The Basics Of Echocardiography For PE: What Must The Vascular Specialist Know, And Is An Emergent Echo Necessary |
Presenter(s):David M. Dudzinski, MD | |
View Abstract | |
7:35 AM - 7:50 AM | What Is State-of-the-Art Medical Therapy For PE |
Presenter(s):Geno J. Merli, MD, MACP, FHM, FSVM | |
View Abstract | |
7:50 AM - 8:00 AM | Intravenous Thrombolytic Therapy For PE: Do We Know More In 2014 |
Presenter(s):Christopher Kabrhel, MD, MPH | |
View Abstract | |
8:00 AM - 8:10 AM | Catheter-Directed Thrombolysis For PE: A Better Lytic Alternative? |
Presenter(s):Jason T. Salsamendi, MD | |
View Abstract | |
8:10 AM - 8:25 AM | Percutaneous Pharmacomechanical Intervention For PE: What Does The Data Say, And Where Must We Go From Here |
Presenter(s):Iris Baumgartner, MD | |
View Abstract | |
8:25 AM - 8:35 AM | Lysis For PE: What About The Nuts And Bolts Heparin, PTT And Fibrinogen Monitoring, And How Do You Know When You Are Done |
Presenter(s):Raghu Kolluri, MD | |
View Abstract | |
8:35 AM - 8:45 AM | Technical Tips For Pharmacomechanical Intervention For PE: How Do I Do It? |
Presenter(s):Jeffrey Y. Wang, MD | |
View Abstract | |
Moderator(s): Michael R. Jaff, DO | |
8:45 AM - 9:15 AM | Case Presentations / Panel Discussion / Questions And Answers |
Panelist(s): Christopher Kabrhel, MD, MPH / Iris Baumgartner, MD / Geno J. Merli, MD, MACP, FHM, FSVM / Jason T. Salsamendi, MD / Jeffrey Y. Wang, MD | |
View Abstract | |
9:15 AM - 9:45 AM | Break Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 42 | |
SESSION 43 SCHEDULE | |
Wednesday
SESSION 43:
MANAGEMENT OF PULMONARY EMBOLISM: THE SPECTRUM AS IT EVOLVES DRUGS, DEVICES AND SURGERY PART 2
Moderators:Michael R. Jaff, DO
|
|
x | |
9:45 AM - 10:00 AM | The SEATTLE Trial: A Breakthrough For PE Treatment? |
Presenter(s):Gregory Piazza, MD, MS | |
View Abstract | |
10:00 AM - 10:10 AM | What Did The SEATTLE Trial Fail To Answer? |
Presenter(s):Clifford M. Sales, MD, MBA | |
View Abstract | |
10:10 AM - 10:20 AM | Vortex Strategy For Massive PE |
Presenter(s):Christopher J. Kwolek, MD | |
View Abstract | |
10:20 AM - 10:35 AM | ECMO And Surgical Thromboembolectomy For Massive PE: When, How, And Why? |
Presenter(s):Thoralf Sundt, MD | |
View Abstract | |
10:35 AM - 10:45 AM | What Is The Modern Algorithm For Management Of Massive And Submassive PE |
Presenter(s):Tod C. Engelhardt, MD | |
View Abstract | |
10:45 AM - 11:00 AM | Iliac Venous Stenosis: When To Look And When To Stent |
Presenter(s):John A. Kaufman, MD | |
View Abstract | |
11:00 AM - 11:15 AM | The Team Approach To PE Management: The Emergence Of National PERT Centers |
Presenter(s):Kenneth Rosenfield, MD | |
View Abstract | |
11:15 AM - 11:45 AM | Challenging Cases And PERT Decisions |
Panelist(s): Tod C. Engelhardt, MD / John A. Kaufman, MD / Christopher J. Kwolek, MD / Gregory Piazza, MD, MS / Kenneth Rosenfield, MD / Thoralf Sundt, MD | |
View Abstract | |
11:45 AM - 12:00 PM | Questions And Answers |
12:00 PM - 1:00 PM | Lunch Break Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 43 | |
SESSION 44 SCHEDULE | |
Wednesday
SESSION 44:
OCCLUSION OF THE DEEP VEINS OF THE LEG: CAUSES, RISKS TO THE PATIENT, AND OPPORTUNITIES FOR TREATMENT
Moderators:Kenneth Ouriel, MD, MBA / Alan Dardik, MD, PhD
|
|
x | |
1:00 PM - 1:05 PM | Large Vein Occlusive Disease: The Magnitude Of The Problem In The Population |
Presenter(s):Peter Gloviczki, MD | |
View Abstract | |
1:06 PM - 1:11 PM | Physiology Of Large Vein Occlusion: A Hemodynamic Explanation For The Post-Thrombotic Syndrome |
Presenter(s):Mark H. Meissner, MD | |
View Abstract | |
1:12 PM - 1:17 PM | Predictors Of Post-Thrombotic Syndrome After DVT: Which Patients Will Have Problems |
Presenter(s):Susan R. Kahn, MD, MSc | |
View Abstract | |
1:18 PM - 1:23 PM | DVT In The Leg: New Modalities For Managing A Lifelong Problem For The Patient |
Presenter(s):Gerard J. O'Sullivan, MD | |
View Abstract | |
1:24 PM - 1:29 PM | Venous Thrombosis: Can We Determine The Age Of The Thrombus And Does It Matter Anyway |
Presenter(s):Cees H.A. Wittens, MD, PhD | |
View Abstract | |
1:30 PM - 1:35 PM | DEBATE: Chronic Femoral DVT Should Not Be Treated With Aggressive Interventions |
Presenter(s):John Blebea, MD, MBA | |
View Abstract | |
1:36 PM - 1:41 PM | DEBATE: Endovascular Interventions Work For Chronic Femoral Occlusions And Should Be Considered In Most Patients |
Presenter(s):Seshadri Raju, MD | |
View Abstract | |
1:42 PM - 1:47 PM | 2014: The Forefront Of New Anticoagulants For DVT |
Presenter(s):Jeffrey W. Olin, DO | |
View Abstract | |
1:48 PM - 1:53 PM | Femoral Vein Excision For Vascular Reconstruction: Techniques To Minimize Post-Thrombotic Symptoms |
Presenter(s):Timur P. Sarac, MD | |
View Abstract | |
1:54 PM - 1:59 PM | Panel Discussion |
END OF SESSION 44 | |
SESSION 45 SCHEDULE | |
Wednesday
SESSION 45:
ACUTE LOWER EXTREMITY DVT: AVOIDING EARLY AND LATE ADVERSE OUTCOMES
Moderators:Samuel R. Money, MD, MBA / Jean-Paul de Vries, MD, PhD
|
|
x | |
2:00 PM - 2:05 PM | Risk Of Pulmonary Embolism With DVT: Which Clots, Who And When |
Presenter(s):Michael R. Jaff, DO | |
View Abstract | |
2:06 PM - 2:11 PM | The Bulls Eye Sign: A New Iliac Vein Marker To Avert The Need For IVUS |
Presenter(s):Enrico Ascher, MD | |
View Abstract | |
2:12 PM - 2:17 PM | Thrombolysis For Acute Deep Venous Thrombosis: Is It Safe, Is It Effective: Lessons From The 2014 Cochrane Update |
Presenter(s):Cynthia K. Shortell, MD | |
View Abstract | |
2:18 PM - 2:23 PM | The EKOS System For Treatment Of Acute DVT: Theory And Practice |
Presenter(s):Anil P. Hingorani, MD | |
View Abstract | |
2:24 PM - 2:29 PM | Newer Methods For Treating Acute DVT: Thrombolysis, Ultrasound, And Mechanical Thrombectomy Devices |
Presenter(s):Robert A. Lookstein, MD, FSIR, FAHA | |
View Abstract | |
2:30 PM - 2:35 PM | Update On The ATTRACT Study Of rt-PA For Acute DVT |
Presenter(s):Suresh Vedantham, MD | |
View Abstract | |
2:36 PM - 2:41 PM | DEBATE: Early Intervention Is Best For Acute Iliofemoral DVT And Prevents Post-Thrombotic Complications |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
View Abstract | |
2:42 PM - 2:47 PM | DEBATE: Antithrombotic Therapy Alone For Acute DVT: Lack Of High Level Evidence For Endovenous Interventions |
Presenter(s):Jeffrey W. Olin, DO | |
View Abstract | |
2:48 PM - 2:56 PM | Panel Discussion |
2:56 PM - 3:15 PM | Break Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 45 | |
SESSION 46 SCHEDULE | |
Wednesday
SESSION 46:
NOVEL BALLOONS, STENTS, THROMBOLYSIS, ULTRASOUND, AND MECHANICAL THROMBECTOMY DEVICES FOR LARGE VEIN OCCLUSIONS
Moderators:Timur P. Sarac, MD / Cees H.A. Wittens, MD, PhD
|
|
x | |
3:16 PM - 3:21 PM | Dedicated Stents For The Venous System: Requirements And Status Of Devices In Clinical Development |
Presenter(s):Gerard J. O'Sullivan, MD | |
View Abstract | |
3:22 PM - 3:27 PM | DEBATE: Currently Marketed Stents Are Suboptimal In The Venous System: The Need For New Devices Engineered For The Veins |
Presenter(s):Cees H.A. Wittens, MD, PhD | |
View Abstract | |
3:28 PM - 3:33 PM | DEBATE: New Devices Are Encouraged But Stent Malfunctions Are Rare In The Venous System, Even With Older Devices |
Presenter(s):Seshadri Raju, MD | |
View Abstract | |
3:34 PM - 3:39 PM | Should Drug-Eluting Balloons Be Considered For Large Vein Stenoses: Theory And Predictions For The Future |
Presenter(s):William A. Gray, MD | |
View Abstract | |
3:40 PM - 3:45 PM | Iliofemoral DVT In Pregnancy: Thrombus Removal Is Safe And Avoids Long-Term Morbidity |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
View Abstract | |
3:46 PM - 3:51 PM | Long-Term Outcomes After Trellis Thrombectomy For DVT |
Presenter(s):Rabih A. Chaer, MD | |
View Abstract | |
3:52 PM - 3:57 PM | Tips And Tricks For Recanalization Of Occluded Large Veins: The Role Of The Ekosonic System |
Presenter(s):Jean-Paul de Vries, MD, PhD | |
View Abstract | |
3:58 PM - 4:03 PM | DEBATE: Ultrasound-Enhanced Thrombolysis Yields No Benefit Over Thrombolysis Alone |
Presenter(s):Iris Baumgartner, MD | |
View Abstract | |
4:04 PM - 4:09 PM | DEBATE: Nonsense; EKOS Thrombolysis For Acute DVT Is A Game Changer |
Presenter(s):Mark J. Garcia, MD | |
View Abstract | |
4:10 PM - 4:15 PM | Panel Discussion |
END OF SESSION 46 | |
SESSION 47 SCHEDULE | |
Wednesday
SESSION 47:
TREATMENT OF INFERIOR VENA CAVA THROMBUS, MALIGNANCY, INJURY AND OCCLUSION
|
|
x | |
4:16 PM - 4:21 PM | Treatment Of Chronic IVC Occlusion With Stents: Which Patients, Which Stents, And Results |
Presenter(s):Seshadri Raju, MD | |
View Abstract | |
4:22 PM - 4:27 PM | IVC Resection And Reconstruction For Malignancy: Tips And Tricks |
Presenter(s):William J. Quinones-Baldrich, MD | |
View Abstract | |
4:28 PM - 4:33 PM | Aggressive Management Of Acute Thrombosis Of The Inferior Vena Cava |
Presenter(s):Bo G. Eklof, MD, PhD | |
View Abstract | |
4:34 PM - 4:39 PM | Robotic Removal Of Malfunctioning IVC Filters: A Case And Potential For The Future |
Presenter(s):Samuel R. Money, MD, MBA | |
View Abstract | |
4:40 PM - 4:45 PM | Exsanguinating Hemorrhage From Iatrogenic IVC Injury: Presentation, Management And Outcome |
Presenter(s):Peter Gloviczki, MD | |
View Abstract | |
4:46 PM - 4:51 PM | Getting Paid For Inferior Vena Caval Procedures: Newer CPT Codes And When To Use Them |
Presenter(s):Sean P. Roddy, MD | |
View Abstract | |
4:52 PM - 5:00 PM | Panel Discussion |
END OF SESSION 47 |